Hoxton Ventures Research
Investment Thesis
Hoxton Ventures is a London-based, partner-only early-stage venture capital firm founded in 2013 by Hussein Kanji and Rob Kniaz, built explicitly to bring a "Silicon Valley mindset" to European venture investing. The firm describes itself as deliberately anti-thematic: rather than committing to a fixed set of sectors, the partners look for founders building something of significance in categories that are not yet obvious, and write the check on conviction in the team and market rather than a pre-defined thesis. Hoxton places heavy emphasis on helping its companies tackle the US market early, drawing on the partners' combined 50+ years of Silicon Valley tenure and senior relationships there. The firm is explicit that its business model is about maximizing upside rather than minimizing early-stage risk, and it is comfortable investing in imperfect, unproven companies if the team and market are large enough.
Sector Focus
True to its anti-thematic positioning, Hoxton's live portfolio spans biotech and life sciences (Baseimmune, Biocortex, CCX Pharma, Ephla Bio, Eterna Regeneratives, Inoviv, Multiomic Health, Ochre Bio, Panacea, Panakeia, Pear Bio, Pentabind, Peptone, Valink Therapeutics), AI/deep tech (CuspAI, DruidAI, Finster, Malted AI, Machenta, NoMagic, Milvus Advanced, Universal Quantum), fintech and crypto (Deblock, Formance), security (Behavox, Boost Security), proptech (Giraffe360), HR/work tech (Juno), consumer/edtech (Preply, Roli), and travel (TourRadar). Recent public commentary (a 2026 whitepaper titled "Europe's Sputnik Moment in AI") and participation in NVIDIA's £2B UK AI ecosystem initiative signal a growing tilt toward AI and deep tech, particularly companies spinning out of UK research institutions (Imperial College London, Oxford, University of Sussex).
Stage Focus
Hoxton is a pre-seed and seed specialist. The firm typically leads or co-leads the first institutional round a company raises, and reserves capital to follow on through later stages of a company's journey.
Check Size
Typical checks run $500K–$5M, though the firm has gone as low as $250K and as high as $10M for standout opportunities. Hoxton targets an ownership position of roughly 10–20% and is explicit that it is not rigidly bound by a particular check size or ownership percentage.
Lead Tendency
Hoxton leads. The firm says it "often" writes the first large check a company receives and is comfortable being the sole institutional investor, while remaining happy to invest alongside others.
Recent Activity
Hoxton has been active through 2025 and 2026: it led Fluent's $7.5M seed round (March 2024), expanded its team and formalized a US presence by relocating Partner Payton Dobbs to San Francisco and adding Isabel Fox (Head of Investor Relations) and Rishabh Kaul (Venture Partner) in September 2025, and was one of five firms selected to partner with NVIDIA on a £2 billion UK AI investment initiative alongside Accel, Air Street Capital, Balderton, and Phoenix Court (September 2025). Portfolio company CuspAI raised a $100M Series A in September 2025 (led by NEA and Temasek, with Hoxton among the startup's earlier backers), and portfolio company Avantia Law, an AI-native legal services platform, was acquired by Carta in May 2026 — one of nine total acquisitions across Hoxton's portfolio history.
Portfolio Highlights
Hoxton's site reports 90 portfolio companies in total, 3 IPOs in ten years, 9 acquisitions, a 67% follow-on rate, $369M total capital raised, and $4.68B in market cap created across the portfolio. Its best-known outcomes are Darktrace (IPO) and Deliveroo (IPO), both early Hoxton investments, alongside Preply (unicorn-track language-learning marketplace) and the recently exited Avantia Law (acquired by Carta, 2026). The live "active" portfolio includes 59+ companies spanning biotech, AI, fintech, security, and proptech, with recent additions including Eterna Regeneratives, Everbloom, Machenta, Mubit, Otera, Panacea, and Prefrontal.
Team
- Hussein Kanji — Partner (Founder & Managing Partner); a Midas List "newcomer" profiled by Forbes as an "outsider" bringing Silicon Valley discipline to European VC.
- Payton Dobbs — Operating Partner; over 20 years in leadership roles at Google and Nest (including GM of Nest Labs EMEA); relocated to San Francisco in 2025 to anchor Hoxton's US presence.
- Midge Mazzier — Associate Partner.
- Rishabh Kaul — Venture Partner; former leadership at Appsmith, co-founder of Belong.co, early employee at GreyOrange; active angel investor in 20+ startups.
- Rob Ludwig — Chief Operating Officer.
- Dahlia Jacobs — Finance Director.
- Sarah Manderson — Legal Director.
- Julie Marechal — Executive Assistant.
- Skyla McDonald — Executive Assistant & Office Manager.
- Rob Kniaz — Partner Emeritus; Hoxton co-founder.
Decision Process
Hoxton describes itself as "deliberately a partner-only firm," implying investment decisions run through the partnership rather than a large associate-driven pipeline or formal investment committee.
Founder Preferences
Hoxton backs "brilliant people and products," welcoming young or first-time founders who are technical or domain experts in their field. The firm reports that 79% of its founders have a technical background, 55% of portfolio companies were founded by immigrants, 43% by minorities, and 18% by women. Founder testimonials consistently emphasize Hoxton's willingness to move fast, take a board seat through difficult periods (Darktrace, Raptor Supplies), and back category-defining ideas that other investors found too early or too complex (Deblock, FINESSE).
Geographic Focus
Hoxton invests primarily in UK and European founders, with an explicit mandate to help those companies expand into the US market early using the partners' Silicon Valley networks. The firm is headquartered at 55 New Oxford Street, London, and has established a physical presence in San Francisco via Partner Payton Dobbs.